Search
Close this search box.
Trending now:  
Valvular and perivalvular thrombus after TAVR: Risks and Outcomes
Dynamic Coronary Roadmap Reduces Contrast Use in Percutaneous Coronary Interventions
Role of Left Ventricular Ejection Fraction in Modern High-Risk PCI with pLVAD Support
TAVI Matches SAVR in Lower Risk Aortic Valve Patients: 10 year outcomes
Lifelong risk of stroke after TAVR: Findings from SwissTAVI Registry

Content for healthcare professionals only

Podcast |

Inflammation as predictor of future cardiovascular event risk

11 Apr 2023
OCT IVUS angiography
Cardiology Update
Cardiology Update
Inflammation as predictor of future cardiovascular event risk
/

Both inflammation and hyperlipidemia contribute to cardiovascular disease. However in patients receiving statin therapy the relative contributions of inflammation and hyperlipidemia to future CV risk can change. As a result, this has implications on adjunctive therapy choice.

In this episode, Dr. Chadi Alraies discusses a recent study that evaluated high sensitivity CRP and LDL-C as predictors of cardiovascular event risk in patients on statin therapy.

For more cardiology research news join our newsletter or follow us on TwitterFacebookLinkedIn or Instagram

Original article: Ridker PM et al. Lancet. 2023 Mar 3;S0140-6736(23)00215-5.

Share:

Related Topics